ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 229 filers reported holding ARRAY BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $15,005,000 | +69.0% | 323,883 | -11.1% | 0.61% | +69.5% |
| Q1 2019 | $8,878,000 | +71.1% | 364,166 | 0.0% | 0.36% | +62.6% |
| Q4 2018 | $5,189,000 | -6.3% | 364,166 | 0.0% | 0.22% | +10.4% |
| Q3 2018 | $5,535,000 | +28.8% | 364,166 | +42.2% | 0.20% | +23.3% |
| Q2 2018 | $4,297,000 | +68.7% | 256,056 | +64.1% | 0.16% | +64.6% |
| Q1 2018 | $2,547,000 | – | 156,056 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |